SG Americas Securities LLC Reduces Position in Bath & Body Works, Inc. $BBWI

SG Americas Securities LLC decreased its position in Bath & Body Works, Inc. (NYSE:BBWI) by 78.9% during the 1st quarter, Holdings Channel reports. The firm owned 98,451 shares of the company’s stock after selling 367,887 shares during the period. SG Americas Securities LLC’s holdings in Bath & Body Works were worth $1,838,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Global Retirement Partners LLC purchased a new stake in Bath & Body Works during the 4th quarter valued at $31,000. Activest Wealth Management purchased a new position in shares of Bath & Body Works in the fourth quarter valued at about $32,000. Geneos Wealth Management Inc. increased its position in shares of Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after acquiring an additional 801 shares during the period. Parallel Advisors LLC raised its stake in shares of Bath & Body Works by 42.6% during the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock valued at $38,000 after acquiring an additional 567 shares during the last quarter. Finally, Danske Bank A S bought a new position in shares of Bath & Body Works during the third quarter valued at about $39,000. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Trading Down 1.9%

Shares of BBWI opened at $21.95 on Friday. Bath & Body Works, Inc. has a 1-year low of $14.27 and a 1-year high of $33.96. The firm’s 50-day moving average price is $19.39 and its 200-day moving average price is $20.37. The firm has a market capitalization of $4.42 billion, a price-to-earnings ratio of 6.17, a PEG ratio of 2.22 and a beta of 1.38.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.03. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The company had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.36 billion. During the same period in the prior year, the firm earned $0.49 earnings per share. Bath & Body Works’s revenue was down 3.2% on a year-over-year basis. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, research analysts forecast that Bath & Body Works, Inc. will post 2.62 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, June 19th. Stockholders of record on Friday, June 5th were given a $0.20 dividend. The ex-dividend date of this dividend was Friday, June 5th. This represents a $0.80 annualized dividend and a dividend yield of 3.6%. Bath & Body Works’s dividend payout ratio is currently 22.47%.

Analyst Upgrades and Downgrades

BBWI has been the subject of a number of analyst reports. Weiss Ratings lowered shares of Bath & Body Works from a “hold (c-)” rating to a “sell (d+)” rating in a report on Tuesday, June 2nd. Piper Sandler began coverage on Bath & Body Works in a research report on Friday, May 15th. They set a “neutral” rating and a $20.00 price target for the company. Telsey Advisory Group dropped their price objective on Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating for the company in a report on Thursday, May 28th. Wells Fargo & Company increased their price objective on Bath & Body Works from $25.00 to $26.00 and gave the stock an “overweight” rating in a report on Tuesday, June 23rd. Finally, TD Cowen lifted their price objective on Bath & Body Works from $20.00 to $25.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Three investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $22.00.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.